Cinematic Virtual Reality Intervention for Improving Psychosocial Functioning in Individuals With Schizophrenia
The Use of Virtual Reality Application in Improving Psychosocial Dysfunction in Schizophrenia
1 other identifier
interventional
37
1 country
1
Brief Summary
Virtual reality (VR) is a novel and innovative intervention method increasingly used in psychiatric research and treatment. VR allows individuals to experience realistic, everyday social situations in a safe and controlled environment. This study aims to examine the effects of a cinematic VR-based psychosocial intervention on individuals with schizophrenia who experience reduced psychosocial functioning and social isolation. In this study, a Cinematic Virtual Reality Treatment Program (cVR-PTP) consisting of 12 weekly sessions was developed. Each session focuses on real-life social situations designed to support social interaction and daily functioning. The intervention aims to contribute to improvements in psychosocial functioning, social engagement, and overall functioning in individuals with schizophrenia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable schizophrenia
Started Apr 2023
Shorter than P25 for not_applicable schizophrenia
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 12, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 15, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 17, 2024
CompletedFirst Submitted
Initial submission to the registry
December 24, 2025
CompletedFirst Posted
Study publicly available on registry
January 8, 2026
CompletedJanuary 12, 2026
December 1, 2025
11 months
December 24, 2025
January 8, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Psychososcial Functioning
Psychosocial functioning refers to an individual's ability to interact with their environment and to perform effectively in various social roles, such as being an employee, student, spouse, family member, or friend. This definition also encompasses individuals' capacity to fulfill these roles, engage in self-care, and derive satisfaction from leisure and recreational activities. In order to measure psychososcial functioning in detail, Social Functioning Scale (SFS) was used. SFS is a self-report scale that aims to measure social functioning in schizophrenia considering the period of last three months. The scale has seven specific areas of social functioning including social engagement/withdrawal, interpersonal behavior, recreation, pro-social activities, independence-performance, independence-competence and employment.
3 months
Psychosocial Functioning
In order to measure psychosocil functioning, Personal and Social Performance Scale (PSP) was used. PSP is an interview-based evaluation scale. It provides an assessment in functioning across four dimensions including socially useful activities, personal and social relationships, self-care, disturbing and aggressive behaviors. Each dimension is rated at six levels (absent, mild, manifest but not marked, marked, severe, very severe). Although each dimension is rated individually, a single score of social functioning is obtained ranging from 0 to 100. Higher score indicates better functioning.
4 weeks
Secondary Outcomes (1)
Sense of Presence
1 week
Study Arms (2)
Cinematic Virtual Reality Psychososcial Treatment Program Group
EXPERIMENTALParticipants received cinematic VR sessions in this group on a weekly basis during 12 weeks
Control Group - Face to Face Interviews
NO INTERVENTIONThis group consists of individuals with schizophrenia. Participants in this group did not receive the virtual reality intervention. They participated in weekly face-to-face, non-interventional interviews as part of treatment as usual for 12 weeks on a weekly basis.
Interventions
cVR-PTP 1. Week - Orientation to the Virtual Environment: Ability to use the VR headset, visual-spatial awareness related to the virtual environment 2. Week - Orientation to the Virtual Environment: Ability to use the VR headset, visual-spatial awareness related to the virtual environment 3. Week - Self-Care: Waking up in the morning, taking a shower 4. Week - Social Interaction: Waiting at a crowded public transport stop, interacting with others 5. Week - Mobility: Traveling with others on a tram 6. Week - Mobility: Traveling with others on a ferry 7. Week - Mobility and Daily Living Activities: Shopping at a traditional bazaar 8. Week - Social Interaction: Going alone to a café 9. Week - Daily Living Activities: Experiencing a grocery shopping 10. Week - Independent Time Activities - Social Interaction: Participating in a cooking workshop 11. Week - Social Interaction: watching aTV show with others 12. Week - Social Interaction: Being in a pleasant family and friends setting
Eligibility Criteria
You may qualify if:
- Clinical stability over the past 12 weeks
- No changes in antipsychotic medication during last 6 monhts
- Having a score ≤70 on the PSP and and ≤61 on the Social and Occupational Functioning Assessment Scale (SOFAS)
You may not qualify if:
- Experienced a psychotic episode or suicide attempt in the past 12 weeks
- Received electroconvulsive therapy in the past 6 months
- Having a diagnosis of a serious physical or neurological disorder that could impact clinical functioning or sensory systems (visual or auditory), alcohol or substance use disorder, intellectual disability, or a history of epilepsy
- Participants with an identified suicide risk, self-harm tendencies, or violent behavior
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Psychiatry
Izmir, Balçova, 35330, Turkey (Türkiye)
Related Publications (6)
Bell, I.H., Pot-Kolder, R., Rizzo, A. et al. Advances in the use of virtual reality to treat mental health conditions. Nat Rev Psychol 3, 552-567 (2024). https://doi.org/10.1038/s44159-024-00334-9
BACKGROUNDWitmer B. G., Jerome C. J. and Singer M. J. , "The Factor Structure of the Presence Questionnaire," in Presence, vol. 14, no. 3, pp. 298-312, June 2005, doi: 10.1162/105474605323384654.
BACKGROUNDPriebe S. Social outcomes in schizophrenia. Br J Psychiatry Suppl. 2007 Aug;50:s15-20. doi: 10.1192/bjp.191.50.s15.
PMID: 18019039BACKGROUNDBosc M. Assessment of social functioning in depression. Compr Psychiatry. 2000 Jan-Feb;41(1):63-9. doi: 10.1016/s0010-440x(00)90133-0.
PMID: 10646621BACKGROUNDSchroeder AH, Bogie BJM, Rahman TT, Therond A, Matheson H, Guimond S. Feasibility and Efficacy of Virtual Reality Interventions to Improve Psychosocial Functioning in Psychosis: Systematic Review. JMIR Ment Health. 2022 Feb 18;9(2):e28502. doi: 10.2196/28502.
PMID: 35179501BACKGROUNDWiebe A, Kannen K, Selaskowski B, Mehren A, Thone AK, Pramme L, Blumenthal N, Li M, Asche L, Jonas S, Bey K, Schulze M, Steffens M, Pensel MC, Guth M, Rohlfsen F, Ekhlas M, Lugering H, Fileccia H, Pakos J, Lux S, Philipsen A, Braun N. Virtual reality in the diagnostic and therapy for mental disorders: A systematic review. Clin Psychol Rev. 2022 Dec;98:102213. doi: 10.1016/j.cpr.2022.102213. Epub 2022 Oct 30.
PMID: 36356351BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Köksal Alptekin, MD, Professor
Dokuz Eylul University
- PRINCIPAL INVESTIGATOR
Faik Kartelli, PhD
Dokuz Eylul University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- The rater of Personal and Social Performance Scale was blinded to the group assignment.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr
Study Record Dates
First Submitted
December 24, 2025
First Posted
January 8, 2026
Study Start
April 12, 2023
Primary Completion
March 15, 2024
Study Completion
September 17, 2024
Last Updated
January 12, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
De-identified individual participant data that underlie the results reported in this study will be shared upon reasonable request to the corresponding author, beginning after publication of the primary results.